Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ascendis Pharma A/S (ASND) vs Dow Inc (DOW) Price & Performance

Ascendis Pharma A/STrade

Price performance (Past 24H)

Key statistics

Ascendis Pharma A/S vs Dow Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Dow Inc trades at $31.07 (market cap $22.58B). The key difference: Dow Inc is the larger of the two by market cap, and Dow Inc pays a 4.48% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.

ASNDDOW
Market Cap
$16.67B$22.58B
Sector
HealthBasic Materials
52-Week High
$277.18$41.87
52-Week Low
$189.74$20.65
Enterprise Value
$17.04B$38.27B
Dividend Yield
4.48%

Returns comparison

Trailing returns across standard periods

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Read more on ASND

About Dow Inc

Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.

Read more on DOW